Analysis of both the Surveillance, Epidemiology and End Results (SEER) [4] and the National Cancer Database (NCD) [8] datasets has confirmed that ER+/PR- breast cancer has worse survival than ER+/PR + breast cancers. This evidence concerns the gene ESR1 and breast carcinoma.